Dennys Reyes Candedo, MD
Neurology · Boynton Beach, FLNPI 1245598036
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (38.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Penumbra, Inc. accounts for 75.8% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $9,333, more than ten times the $77 reported in 2019.
Across 183 payments — averaging $106.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$15K
- Stryker$4K
- Cardiva Medical, Inc.$252
- Microvention, Inc.$240
- Medtronic$185
- Imperative Care, Inc$109
- plus $254 from 6 others
What the payments were for
- Consulting fees$2,00010%
- Speaking & faculty fees$7,50039%
- Travel & lodging$3,14116%
- Food & beverage$6,73735%
- Education$200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 106 | $14,696 |
| Stryker | 50 | $3,662 |
| Cardiva Medical, Inc. | 5 | $252 |
| Microvention, Inc. | 6 | $240 |
| Medtronic | 5 | $185 |
| Imperative Care, Inc | 3 | $109 |
| Vital Connect, Inc | 1 | $67 |
| Terumo Medical Corporation | 2 | $58 |
| Scientia Vascular | 1 | $49 |
| AbbVie | 2 | $42 |
| CSL Behring | 1 | $20 |
| Chiesi USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Smart Coil$5,990
- Penumbra System$5,031
- SURPASS EVOLVE$2,455
- RED 72$1,522
- Penumbra Coil 400$609
- AXS CATALYST 7$349
- Jet 7$241
- AXS INFINITY LS$219
- Cardiva VASCADE MVP VVCS 6-12F$129
- TREVO$119
- Benchmark$119
How this compares
$19,398 in reported general payments places this provider in the 80th percentile of 1,434 neurology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 16 | $147 |
| ClopidogrelClopidogrel Bisulfate | 34 | $104 |
| Atorvastatin Calcium | 12 | $15 |
Paid to pharmacies, not to this prescriber.
Other neurology in Boynton Beach
- Arif DalviBoynton Beach$147K
- Stuart IsaacsonBoca Raton$3.9M
- Selim BenbadisTampa$2.1M
- Derrick RobertsonTampa$1.8M
- Robert HauserTampa$1.6M
- David RoseTampa$1.4M
- Matthew BakerNaples$1.4M
- Donald NegroskiSarasota$1.4M
- Mark CascioneTampa$1.2M
- Lance KimOcala$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.